[CHRS] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
06-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 65.95%
YoY- 150.48%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 58,716 60,151 87,643 135,674 83,433 0 1,395 86.45%
PBT -42,869 -50,150 -29,900 60,325 23,618 -43,685 -55,402 -4.18%
Tax 11,560 6,137 5,758 1,294 51 6,012 5,938 11.73%
NP -42,869 -56,287 -29,900 59,031 23,567 -43,638 -55,336 -4.16%
Tax Rate - - - -2.15% -0.22% - - -
Total Cost 101,585 116,438 117,543 76,643 59,866 43,638 56,731 10.19%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -73.01 -93.58 -34.12 43.51 28.25 0.00 -3,966.74 -48.60%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.49 -0.73 -0.40 0.83 0.34 -0.68 -1.08 -12.33%
EPS Diluted -0.49 -0.73 -0.40 0.70 0.32 -0.68 -1.08 -12.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.